OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex molecules. Improving these processes involves modifying various variables, including cell line selection, media composition, and bioreactor conditions. A key goal is to increase antibody production while reducing production cost